| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966334 | Vaccine | 2013 | 5 Pages |
Abstract
Our model provides an assessment of the cost-effectiveness of dengue vaccination in Brazil and incorporates the effect of herd immunity into dengue vaccination cost-effectiveness. Our results demonstrate that at the relatively low vaccine efficacy from the recent Phase 2b dengue vaccine trials, age-targeted vaccination may still be cost-effective provided the total vaccination cost is sufficiently low.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
David P. Durham, Martial L. Ndeffo Mbah, Jan Medlock, Paula M. Luz, Lauren A. Meyers, A. David Paltiel, Alison P. Galvani,